Villablanca, Eduardo J. http://orcid.org/0000-0001-9522-9729
Selin, Katja http://orcid.org/0000-0002-8888-0529
Hedin, Charlotte R. H. http://orcid.org/0000-0002-4921-8516
Article History
Accepted: 8 March 2022
First Online: 19 April 2022
Competing interests
: E.J.V. has received research grants from F. Hoffmann-La Roche. C.R.H.H. has received speaker fees from Takeda, Ferring, AbbVie, and Janssen and consultancy fees from Pfizer. She has acted as local principal investigator for clinical trials for Janssen and GlaxoSmithKline. She has received project grants from Takeda and Tillotts. K.S. declares no competing interests.